These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20652161)

  • 1. Factors associated with the progression of fibrosis on liver biopsy in Alaska Native and American Indian persons with chronic hepatitis C.
    Livingston SE; Deubner H; Bruden DL; McMahon BJ; Homan CE; Townshend-Bulson LJ; Bruce MG; Hennessy TW; Williams JL; Gretch DR
    Can J Gastroenterol; 2010 Jul; 24(7):445-51. PubMed ID: 20652161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steatosis and hepatitis C in an Alaska Native/American Indian population.
    Livingston SE; Deubner H; McMahon BJ; Bruden D; Christensen C; Hennessy TW; Bruce MG; Sullivan DG; Homan C; Williams J; Gretch DR
    Int J Circumpolar Health; 2006 Jun; 65(3):253-60. PubMed ID: 16871831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of end-stage liver disease, hepatocellular carcinoma, and liver-related death by fibrosis stage in the hepatitis C Alaska Cohort.
    Bruden DJT; McMahon BJ; Townshend-Bulson L; Gounder P; Gove J; Plotnik J; Homan C; Hewitt A; Barbour Y; Spradling PR; Simons BC; McArdle S; Bruce M
    Hepatology; 2017 Jul; 66(1):37-45. PubMed ID: 28195349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease.
    Masarone M; La Mura V; Bruno S; Gaeta GB; Vecchione R; Carrino F; Moschella F; Torella R; Persico M
    J Viral Hepat; 2007 Oct; 14(10):714-20. PubMed ID: 17875006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study.
    Ryder SD; Irving WL; Jones DA; Neal KR; Underwood JC;
    Gut; 2004 Mar; 53(3):451-5. PubMed ID: 14960533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aspartate aminotransferase (AST) more than alanine aminotransferase (ALT) levels predict the progression of liver fibrosis in chronic HCV infection].
    Stránský J; Ryzlová M; Striteský J; Horák J
    Vnitr Lek; 2002 Oct; 48(10):924-8. PubMed ID: 16737138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus.
    Brandman D; Pingitore A; Lai JC; Roberts JP; Ferrell L; Bass NM; Terrault NA
    Liver Transpl; 2011 Dec; 17(12):1380-6. PubMed ID: 21770018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.
    Hissar SS; Kumar M; Tyagi P; Goyal A; Suneetha PV; Agarwal S; Rastogi A; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: prospective analysis of 435 liver biopsy pairs.
    Konerman MA; Mehta SH; Sutcliffe CG; Vu T; Higgins Y; Torbenson MS; Moore RD; Thomas DL; Sulkowski MS
    Hepatology; 2014 Mar; 59(3):767-75. PubMed ID: 24436062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance, steatosis, and fibrosis in Egyptian patients with chronic Hepatitis C virus infection.
    Ahmed AM; Hassan MS; Abd-Elsayed A; Hassan H; Hasanain AF; Helmy A
    Saudi J Gastroenterol; 2011; 17(4):245-51. PubMed ID: 21727730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological features and genotype distribution in patients with hepatitis C virus chronic liver disease.
    Abraham R; Ramakrishna B; Balekuduru A; Daniel HD; Abraham P; Eapen CE; Kurian G
    Indian J Gastroenterol; 2009; 28(2):53-8. PubMed ID: 19696989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of hepatic steatosis on the natural history of chronic hepatitis C infection.
    Cross TJ; Quaglia A; Hughes S; Joshi D; Harrison PM
    J Viral Hepat; 2009 Jul; 16(7):492-9. PubMed ID: 19200134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
    Petta S; Cammà C; Di Marco V; Alessi N; Cabibi D; Caldarella R; Licata A; Massenti F; Tarantino G; Marchesini G; Craxì A
    Am J Gastroenterol; 2008 May; 103(5):1136-44. PubMed ID: 18477344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection With Hepatitis C Virus Genotype 3 Is an Independent Risk Factor for End-Stage Liver Disease, Hepatocellular Carcinoma, and Liver-Related Death.
    McMahon BJ; Bruden D; Townshend-Bulson L; Simons B; Spradling P; Livingston S; Gove J; Hewitt A; Plotnik J; Homan C; Espera H; Negus S; Snowball M; Barbour Y; Bruce M; Gounder P
    Clin Gastroenterol Hepatol; 2017 Mar; 15(3):431-437.e2. PubMed ID: 27765729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Data mining of routine laboratory tests can predict liver disease progression in Egyptian diabetic patients with hepatitis C virus (G4) infection: a cohort study of 71 806 patients.
    Saad Y; Awad A; Alakel W; Doss W; Awad T; Mabrouk M
    Eur J Gastroenterol Hepatol; 2018 Feb; 30(2):201-206. PubMed ID: 29099423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrosis Progression in Patients With Chronic Hepatitis C Virus Infection.
    Zeremski M; Dimova RB; Pillardy J; de Jong YP; Jacobson IM; Talal AH
    J Infect Dis; 2016 Oct; 214(8):1164-70. PubMed ID: 27485356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of liver fibrosis among injection drug users with chronic hepatitis C.
    Wilson LE; Torbenson M; Astemborski J; Faruki H; Spoler C; Rai R; Mehta S; Kirk GD; Nelson K; Afdhal N; Thomas DL
    Hepatology; 2006 Apr; 43(4):788-95. PubMed ID: 16557548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C.
    Ghany MG; Lok AS; Everhart JE; Everson GT; Lee WM; Curto TM; Wright EC; Stoddard AM; Sterling RK; Di Bisceglie AM; Bonkovsky HL; Morishima C; Morgan TR; Dienstag JL;
    Gastroenterology; 2010 Jan; 138(1):136-46. PubMed ID: 19766643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C.
    Saadoun D; Asselah T; Resche-Rigon M; Charlotte F; Bedossa P; Valla D; Piette JC; Marcellin P; Cacoub P
    Hepatology; 2006 Jun; 43(6):1337-45. PubMed ID: 16729318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive assessment of liver steatosis and fibrosis in HIV/HCV- and HCV- infected patients.
    Li Vecchi V; Giannitrapani L; Di Carlo P; Mazzola G; Colletti P; La Spada E; Vizzini G; Montalto G; Soresi M
    Ann Hepatol; 2013; 12(5):740-8. PubMed ID: 24018492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.